Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Patients with Esophageal Carcinoma: A Systematic Review and Meta-Analysis.
Systematic comparison of two chemotherapy approaches clarifies treatment choices for resectable esophageal cancer.
This SR+MA addresses the persisting clinical question of perioperative FLOT chemotherapy vs preoperative chemoradiotherapy in resectable esophageal cancer, a debate unresolved by existing RCTs. The pooled analysis provides quantitative comparison of OS, R0 resection, and toxicity, informing multidisciplinary treatment planning for a cancer type with poor overall prognosis.
What the study was
- Study design
- Systematic review and meta-analysis
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- J Gastrointest Cancer
Why it surfaced
Esophageal cancer treatment strategy is an active clinical debate; SR+MA of RCTs provides highest evidence level; directly actionable for surgical oncology decisions.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.